Rapports

Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review

Rapport
Titre
Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review
118.75EUR
Langue
Pages
34
Secteur
Santé
Date
Juillet 2016
Pays
Nigeria
Type de Produit
Company report
Description du rapport

Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fidson Healthcare Plc (Fidson) is a pharmaceutical company which manufactures and distributes healthcare products. The company offers prescription and over the counter (OTC) pharmaceutical products for various therapeutic categories namely antacid and ulcer care, anti-diabetic, anti-diarrhoea, anti-infectives, anti-malaria, cardio-vascular, cough, cold, catarrh, allergies, multivitamin-haemanitics, osteo-care, pain-relievers, and thrombo-prophalytic. The company provides over 200 different drug products and formulations. Some of its major products include antacid suspension classic, ctuxil, paracetamol, iprofloxacin, amino acid intravenous nutritional supplement, fluoxetine, and olanzapine. It markets products under brand names such as Gascol, Meprasil, Biosulin, Peflotab, Ciprotab, Cutenox, and Peflotab, among others. The company partners with Fidson Herbal and CESTRA Neutraceutical. Fidson is headquartered in Lagos, Nigeria.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table des matières

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1 - About the Company 6

Fidson Healthcare Plc - Key Facts 6

Fidson Healthcare Plc - Key Employees 7

Fidson Healthcare Plc - Key Employee Biographies 8

Fidson Healthcare Plc - Major Products and Services 9

Fidson Healthcare Plc - History 11

Fidson Healthcare Plc - Company Statement 12

Fidson Healthcare Plc - Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2 – Company Analysis 14

Fidson Healthcare Plc - Business Description 14

Fidson Healthcare Plc - Corporate Strategy 15

Fidson Healthcare Plc - SWOT Analysis 16

SWOT Analysis - Overview 16

Fidson Healthcare Plc - Strengths 16

Strength - Client and Supplier Base 16

Strength - Dominant Position in Nigeria 16

Strength - Cost Control Drives Profitability 16

Fidson Healthcare Plc - Weaknesses 17

Weakness - Increase in Credit Risk 17

Weakness - Decline in Revenue 17

Fidson Healthcare Plc - Opportunities 18

Opportunity - Growing Pharmaceutical Market in Nigeria 18

Opportunity - Expansion Initiatives 18

Opportunity - Strategic Partnerships 18

Fidson Healthcare Plc - Threats 19

Threat - Competition 19

Threat - Increased Scrutiny on Drug Imports 19

Threat - Increase in Counterfeit Products 19

Fidson Healthcare Plc - Key Competitors 20

Section 3 – Company Financial Ratios 21

Financial Ratios - Capital Market Ratios 21

Financial Ratios - Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios - Interim Ratios 25

Financial Ratios - Ratio Charts 26

Section 4 – Company’s Lifesciences Financial Deals and Alliances 27

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28

Fidson Healthcare Plc, Recent Deals Summary 29

Section 5 – Appendix 30

Methodology 30

Ratio Definitions 30

About GlobalData 34

Contact Us 34

Disclaimer 34

Description de l'éditeur

GlobalData is the premier source of actionable insight into the healthcare industry. With the combined expertise of more than 1,000 researchers, market analysts and consultants, we provide high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

Combining precision with innovation, our research and consulting solutions ensure our clients stay at the forefront of their markets by integrating accurate market forecasts and analysis on the latest trends and developments with the unrivalled expertise of our analyst teams. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence.

 

Contact:  Partner Supportpartnersupport@globaldata.com

                 Sunil Sethia ssethia@globaldata.com